ArticleJournal of clinical laboratory analysis2018

CYP2C19 and ABCB1 genetic polymorphisms correlate with the recurrence of ischemic cardiovascular adverse events after clopidogrel treatment.

Xumin Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.